OCaR1 endows exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic tissue damage.

Calcium signaling Cell biology Ion channels Lysosomes

Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 Apr 2024
Historique:
received: 15 02 2023
accepted: 13 02 2024
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: epublish

Résumé

Regulated exocytosis is initiated by increased Ca2+ concentrations in close spatial proximity to secretory granules, which is effectively prevented when the cell is at rest. Here we showed that exocytosis of zymogen granules in acinar cells was driven by Ca2+ directly released from acidic Ca2+ stores including secretory granules through NAADP-activated two-pore channels (TPCs). We identified OCaR1 (encoded by Tmem63a) as an organellar Ca2+ regulator protein integral to the membrane of secretory granules that controlled Ca2+ release via inhibition of TPC1 and TPC2 currents. Deletion of OCaR1 led to extensive Ca2+ release from NAADP-responsive granules under basal conditions as well as upon stimulation of GPCR receptors. Moreover, OCaR1 deletion exacerbated the disease phenotype in murine models of severe and chronic pancreatitis. Our findings showed OCaR1 as a gatekeeper of Ca2+ release that endows NAADP-sensitive secretory granules with an autoregulatory mechanism preventing uncontrolled exocytosis and pancreatic tissue damage.

Identifiants

pubmed: 38557489
pii: 169428
doi: 10.1172/JCI169428
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Volodymyr Tsvilovskyy (V)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Roger Ottenheijm (R)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Ulrich Kriebs (U)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Aline Schütz (A)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Kalliope Nina Diakopoulos (KN)

Comprehensive Cancer Center München, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Archana Jha (A)

Epithelial Signaling and Transport Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, USA.

Wolfgang Bildl (W)

Institute for Physiology, University of Freiburg, Freiburg, Germany.

Angela Wirth (A)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Julia Böck (J)

Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.

Dawid Jaślan (D)

Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.

Irene Ferro (I)

Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.

Francisco J Taberner (FJ)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
Instituto de Neurociencias de Alicante, Universidad Miguel Hernández-Consejo Superior de Investigaciones Científicas, Sant Joan d'Alacant, Spain.

Olga Kalinina (O)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarbrücken, Germany.

Staffan Hildebrand (S)

Institut für Pharmakologie und Toxikologie, Universität Bonn, Bonn, Germany.

Ulrich Wissenbach (U)

Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Petra Weissgerber (P)

Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Dominik Vogt (D)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Carola Eberhagen (C)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.

Stefanie Mannebach (S)

Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Michael Berlin (M)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Vladimir Kuryshev (V)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Dagmar Schumacher (D)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Koenraad Philippaert (K)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany.

Juan E Camacho-Londoño (JE)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Ilka Mathar (I)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Christoph Dieterich (C)

University Hospital Heidelberg, Department of Medicine III: Cardiology, Angiology and Pneumology, Heidelberg, Germany.

Norbert Klugbauer (N)

Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Fakultät für Medizin, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.

Martin Biel (M)

Center for Integrated Protein Science Munich (CIPS-M) and Center for Drug Research, Department of Pharmacy, Ludwig-Maximilians-Universität München, and DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Christian Wahl-Schott (C)

Walter Brendel Centre of Experimental Medicine, Biomedical Center, Institute of Cardiovascular Physiology and Pathophysiology, Medical Faculty, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.

Peter Lipp (P)

Institute for Molecular Cell Biology, Center for Molecular Signaling (PZMS), Universität des Saarlandes, Homburg, Germany.

Veit Flockerzi (V)

Experimental and Clinical Pharmacology and Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany.

Hans Zischka (H)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany.
Institute of Toxicology and Environmental Hygiene, Technical University Munich, School of Medicine, Munich, Germany.

Hana Algül (H)

Comprehensive Cancer Center München, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Stefan G Lechner (SG)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Marina Lesina (M)

Comprehensive Cancer Center München, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Christian Grimm (C)

Walther-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München, Munich, Germany.
Immunology, Infection and Pandemic Research (IIP), Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Munich, Germany.

Bernd Fakler (B)

Institute for Physiology, University of Freiburg, Freiburg, Germany.

Uwe Schulte (U)

Institute for Physiology, University of Freiburg, Freiburg, Germany.

Shmuel Muallem (S)

Epithelial Signaling and Transport Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, USA.

Marc Freichel (M)

Institute of Pharmacology, Heidelberg University, Heidelberg, Germany.

Classifications MeSH